Examples of using Ebilfumin in English and their translations into Hungarian
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
Do not take Ebilfumin.
Ebilfumin 30 mg hard capsules.
How to store Ebilfumin.
Ebilfumin is a‘generic medicine'.
How is Ebilfumin used?
Medication name Ebilfumin.
How has Ebilfumin been studied?
Other medicines and Ebilfumin.
One 45 mg Ebilfumin capsule.
If you forget to take Ebilfumin.
Ebilfumin 30 mg[for the outer carton only].
One or two 30 mg Ebilfumin capsule(s).
What Ebilfumin looks like and contents of the pack.
Talk to your doctor if this applies to you. Do not take Ebilfumin.
Required number of Ebilfumin capsules(mg of oseltamivir).
Ebilfumin hard capsules are bioequivalent formulations.
The suspension is caused by some of the excipients of Ebilfumin capsules, which are insoluble.
Ebilfumin is an antiviral medicine that contains the active substance oseltamivir.
The appropriate dispenser sizes for taking the correct volume of Ebilfumin suspension(6 mg/ml) are shown below.
Ebilfumin is available as capsules(30, 45 and 75 mg) and can only be obtained with a prescription.
Dosing chart for pharmacy-compounded 6 mg/ml suspension prepared from Ebilfumin capsules for infants and children 1 year of age or older.
Ebilfumin 30 mg hard capsules are available in blister packs or tablet containers of 10.
Detailed information on the home preparation can be found in the package leaflet of Ebilfumin capsules under“Making liquid Ebilfumin at home”.
When Ebilfumin is used during a flu epidemic, this dose can be given for up to six weeks.
Caution should be exercised when preparing liquid Ebilfumin for children and when administering Ebilfumin capsules or liquid Ebilfumin to children.
Ebilfumin is not a vaccine: it treats infection, or prevents the flu virus spreading.
During a flu pandemic, Ebilfumin can also be used to treat or prevent flu in babies below one year of age.
Ebilfumin 30 mg, 45 mg and 75 mg capsules are available for infants and children 1 year of age or older.
A pooled population pharmacokinetic analysis indicates that the Ebilfumin dosage regimen described in Section 4.2 Posology and method of administration results in lower exposure(30% on average across all trimesters) to the active metabolite in pregnant women compared to non-pregnant women.
Ebilfumin is indicated in adults and children including full-term neonates who present with symptoms typical of influenza, when influenza virus is circulating in the community.